No Data
US Stock MarketDetailed Quotes
ABBV AbbVie
Watchlist
135.430
-1.430-1.04% Close 06/06 16:00 ET
135.440+0.010+0.01%
Post 19:29 ET
137.540High134.630Low4.36MVolume
137.470Open136.860Pre Close590.78MTurnover0.25%Turnover Ratio31.87P/E (TTM)238.94BMarket Cap166.20052wk High20.43P/E (Static)1.76BShares130.28952wk Low18.00P/B238.55BFloat Cap167.910Historical High5.71Dividend TTM1.76BShs Float21.189Historical Low4.22%Div YieldTTM2.13%Amplitude135.511Avg Price1Lot Size
Post-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Company
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Revenue Breakdown
Business
Unit:USD
NameYOYOperating income%
HUMIRA--21.24B36.58%
other--11.04B19.02%
SKYRIZI--5.17B8.90%
IMBRUVICA--4.57B7.87%
All other--4.14B7.13%
Botox Therapeutic--2.72B4.68%
Botox Cosmetic--2.62B4.50%
RINVOQ--2.52B4.34%
Vraylar--2.04B3.51%
VENCLEXTA--2.01B3.46%
View all
News
Comments
Skyrizi
$AbbVie(ABBV.US$ Ok you fell off a cliff with humaria you caught a branch with skyrizi with top line 7 b a year at its peak. which is what maybe 3x current position? you have literal goldmine in allergens pipeline. I peg allergens true value at $81 billion which is about farless the 44b you paid.
Read more